Search Results - "Neoplasms, Second Primary/epidemiology"
-
1
Authors: et al.
Contributors: et al.
Source: Br J Cancer
British journal of cancer, vol. 130, no. 6, pp. 976-986
Heymer, Emma J; Hawkins, Michael M; Winter, David L; Teepen, Jop C; Sunguc, Ceren; Ronckers, Cécile M; Allodji, Rodrigue S; Alessi, Daniela; Sugden, Elaine; Belle, Fabiën N; Bagnasco, Francesca; Byrne, Julianne; Bárdi, Edit; Garwicz, Stanislaw; Grabow, Desiree; Jankovic, Momcilo; Kaatsch, Peter; Kaiser, Melanie; Michel, Gisela; Schindera, Christina; ... (2024). Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. British journal of cancer, 130(6), pp. 976-986. Nature Publishing Group 10.1038/s41416-024-02577-y <http://dx.doi.org/10.1038/s41416-024-02577-y>
Heymer, E J, Hawkins, M M, Winter, D L, Teepen, J C, Sunguc, C, Ronckers, C M, Allodji, R S, Alessi, D, Sugden, E, Belle, F N, Bagnasco, F, Byrne, J, Bárdi, E, Garwicz, S, Grabow, D, Jankovic, M, Kaatsch, P, Kaiser, M, Michel, G, Schindera, C, Haddy, N, Journy, N, Česen Mazić, M, Skinner, R, Kok, J L, Gunnes, M W, Wiebe, T, Sacerdote, C, Maule, M M, Terenziani, M, Jakab, Z, Winther, J F, Lähteenmäki, P M, Zadravec Zaletel, L, Haupt, R, Kuehni, C E, Kremer, L C, de Vathaire, F, Hjorth, L & Reulen, R C 2024, 'Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study', British Journal of Cancer, vol. 130, no. 6, pp. 976-986. https://doi.org/10.1038/s41416-024-02577-ySubject Terms: Adult, Adolescent, Glioma/epidemiology, 610 Medicine & health, Central Nervous System Neoplasms/epidemiology, Article, Europe/epidemiology, Leukemia/epidemiology, 12. Responsible consumption, Central Nervous System Neoplasms, 360 Social problems & social services, Risk Factors, Meningeal Neoplasms, Humans, Meningioma/etiology, Survivors, 2. Zero hunger, Meningeal Neoplasms/epidemiology, Leukemia, Incidence, Middle Aged, Meningioma/complications, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/etiology, Neoplasms, Second Primary, Glioma, 3. Good health, Europe, Meningioma, Adolescent [MeSH], 631/67/2324, Survivors [MeSH], Adult [MeSH], Meningeal Neoplasms/epidemiology [MeSH], Central Nervous System Neoplasms/epidemiology [MeSH], Humans [MeSH], Incidence [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], 631/67/2332, Leukemia/epidemiology [MeSH], Europe/epidemiology [MeSH], Meningioma/complications [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], 692/308/174, 692/499, Meningioma/etiology [MeSH], 631/67/1922, Neoplasms, Second Primary/etiology [MeSH], Glioma/epidemiology [MeSH], article
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38243010
https://serval.unil.ch/notice/serval:BIB_5E41358F4FAC
https://serval.unil.ch/resource/serval:BIB_5E41358F4FAC.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5E41358F4FAC7
https://boris.unibe.ch/191942/
https://repository.publisso.de/resource/frl:6493009
https://pure.au.dk/portal/en/publications/cb3e8729-5979-487e-ad3e-52d0eda75cf0
http://www.scopus.com/inward/record.url?scp=85182705638&partnerID=8YFLogxK
https://doi.org/10.1038/s41416-024-02577-y -
2
Authors: et al.
Contributors: et al.
Source: Blood Cancer J
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Blood Cancer Journal, 14, 1, pp. 150Subject Terms: Male, Adult, Adolescent, Primary and Community Care - Radboud University Medical Center, Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy, Article, Young Adult, SDG 3 - Good Health and Well-being, Cancer Survivors, Risk Factors, Journal Article, Humans, Hematopoietic Stem Cell Transplantation/adverse effects, Child, Haematology - Radboud University Medical Center, RC254-282, Incidence, Hematopoietic Stem Cell Transplantation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Infant, Neoplasms, Second Primary, Precursor Cell Lymphoblastic Leukemia-Lymphoma, 3. Good health, Child, Preschool, Neoplasms, Second Primary/epidemiology, Female, Cancer Survivors/statistics, Adolescent [MeSH], Female [MeSH], 631/67/2324, Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology [MeSH], 631/67/1990/283/2125, Adult [MeSH], Humans [MeSH], Incidence [MeSH], Risk Factors [MeSH], Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], Infant [MeSH], Male [MeSH], 692/499, Young Adult [MeSH], Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy [MeSH], Neoplasms, Second Primary/etiology [MeSH], Child [MeSH], article, Child, Preschool [MeSH], Cancer Survivors/statistics & numerical data
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39198413
https://doaj.org/article/dd1578a6e4ab4a39aa7be9fb7ad260a1
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/310238
https://dspace.library.uu.nl/handle/1874/455759
https://hdl.handle.net/1887/4212852
https://repository.ubn.ru.nl//bitstream/handle/2066/310238/310238.pdf
https://hdl.handle.net/2066/310238
https://repository.publisso.de/resource/frl:6507046 -
3
Authors: et al.
Source: Cancer Causes Control
Subject Terms: ddc:610, Original Paper, 03 medical and health sciences, 0302 clinical medicine, Adolescent [MeSH], Humans [MeSH], Neoplasms/epidemiology [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], Nested case control study, Neoplasms/drug therapy [MeSH], Neoplasms/radiotherapy [MeSH], Case-Control Studies [MeSH], Childhood cancer, Chemotherapy, Neoplasms, Second Primary/etiology [MeSH], Child [MeSH], Radiotherapy, Subsequent primary neoplasm, Adolescent, Neoplasms, Case-Control Studies, Humans, Neoplasms, Second Primary, Child, 3. Good health
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37530985
https://repository.publisso.de/resource/frl:6508673
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/38665
https://doi.org/10.1007/s10552-023-01760-5
https://opus.bibliothek.uni-wuerzburg.de/files/38665/s10552-023-01760-5.pdf
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-386657 -
4
Authors: et al.
Contributors: et al.
Source: Reulen, R C, Winter, D L, Diallo, I, Veres, C, Llanas, D, Allodji, R S, Bagnasco, F, Bárdi, E, Feijen, E A M, Alessi, D, Fidler-Benaoudia, M M, Høgsholt, S, Teepen, J C, Linge, H, Haddy, N, Byrne, J, Debiche, G, Grabow, D, Gudmundsdottir, T, Fauchery, R, Zrafi, W, Michel, G, Øfstaas, H, Kaatsch, P, Vu-Bezin, G, Jenkinson, H, Kaiser, M, Skinner, R, Cole, T, Waespe, N, Sommer, G, Nordenfelt, S, Jankovic, M, Lähteenmäki Taalas, T, Maule, M M, Van Der Pal, H J H, Ronckers, C M, Van Leeuwen, F E, Kok, J L, Terenziani, M, Winther Gunnes, M, Wiebe, T, Sacerdote, C, Jakab, Z, Haupt, R, Lähteenmäki, P M, Zadravec Zaletel, L, Kuehni, C E, Falck Winther, J, Kremer, L C M, Hjorth, L, De Vathaire, F & Hawkins, M M 2023, 'Risk Factors for Primary Bone Cancer after Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study', Journal of Clinical Oncology, vol. 41, no. 21, pp. 3735-3746. https://doi.org/10.1200/JCO.22.02045
Subject Terms: Alkylating Agents, Adolescent, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, Bone Neoplasms, [SDV.CAN] Life Sciences [q-bio]/Cancer, Cancer Survivors, Risk Factors, Humans, Ifosfamide, Child, Cyclophosphamide, Osteosarcoma, Neoplasms, Second Primary, Dose-Response Relationship, Radiation, ta3122, Neoplasms, Second Primary / epidemiology, ta3123, 3. Good health, [SDV] Life Sciences [q-bio], [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Case-Control Studies, Procarbazine, Neoplasms, Second Primary / chemically induced, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Osteosarcoma / epidemiology, Follow-Up Studies
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37235821
http://juuli.fi/Record/0676799823
https://doi.org/10.1200/JCO.22.02045
https://hal.science/hal-04191667v1
https://doi.org/10.1200/jco.22.02045
https://hal.science/hal-04250853v1
https://doi.org/10.1200/jco.22.02045
https://pure.amsterdamumc.nl/en/publications/75af13aa-504d-4e4c-bd7f-7e2e546fa5bf
https://doi.org/10.1200/JCO.22.02045
https://inserm.hal.science/inserm-04438098v1
https://doi.org/10.1200/jco.22.02045
http://www.scopus.com/inward/record.url?scp=85165219722&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/eb9bd280-d066-46de-9fb4-6d16f3803bf2
https://doi.org/10.1200/JCO.22.02045 -
5
Authors:
Source: Radiat Oncol
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)Subject Terms: Male, Adult, Transplantation Conditioning, Carcinogenesis, R895-920, 610 Medizin, Secondary solid malignancies, Total body irradiation, Low-dose radiotherapy, Secondary solid malignancies, Allogeneic hematopoietic stem cell transplantation, Carcinogenesis, Acute myeloid leukemia, Medical physics. Medical radiology. Nuclear medicine, Cancer Survivors, Risk Factors, Total body irradiation, Humans, Transplantation, Homologous, RC254-282, Retrospective Studies, ddc:610, Acute myeloid leukemia, Research, Hematopoietic Stem Cell Transplantation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Whole-Body Irradiation/adverse effects [MeSH], Cancer Survivors/statistics, Female [MeSH], Follow-Up Studies [MeSH], Leukemia, Myeloid, Acute/etiology [MeSH], Adult [MeSH], Low-dose radiotherapy, Humans [MeSH], Leukemia, Myeloid, Acute/mortality [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Allogeneic hematopoietic stem cell transplantation, Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], Male [MeSH], Transplantation Conditioning/adverse effects [MeSH], Neoplasms, Second Primary/etiology [MeSH], Transplantation, Homologous [MeSH], Neoplasms, Second Primary, Middle Aged, Leukemia, Myeloid, Acute, Female, Whole-Body Irradiation, Follow-Up Studies
File Description: application/pdf
-
6
Authors: et al.
Source: Blood Cancer J
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)Subject Terms: Male, Adult, Aged, 80 and over, Cancer Research, Adolescent, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoplasms, Second Primary, Middle Aged, Prognosis, Article, Leukemia, Myeloid, Acute, Young Adult, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Integrative Biomedicine [Topic 3], Humans, Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], 692/308/174, Male [MeSH], 692/308, Prognosis [MeSH], Young Adult [MeSH], Neoplasms, Second Primary/etiology [MeSH], Leukemia, Myeloid, Acute/therapy [MeSH], article, Female, RC254-282, Aged, Retrospective Studies, Follow-Up Studies
File Description: application/pdf
-
7
Authors: et al.
Contributors: et al.
Source: Cancer
Cancer, 129, 3, pp. 426-440
Cancer, vol. 129, no. 3, pp. 426-440
Dudley, Isabelle M; Sunguc, Ceren; Heymer, Emma J; Winter, David L; Teepen, Jop C; Belle, Fabiën N; Bárdi, Edit; Bagnasco, Francesca; Gudmundsdottir, Thorgerdur; Skinner, Roderick; Michel, Gisela; Byrne, Julianne; Øfstaas, Hilde; Jankovic, Momcilo; Mazić, Maja Česen; Mader, Luzius; Loonen, Jaqueline; Garwicz, Stanislaw; Wiebe, Thomas; Alessi, Daniela; ... (2023). Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer, 129(3), pp. 426-440. John Wiley & Sons 10.1002/cncr.34561 <http://dx.doi.org/10.1002/cncr.34561>Subject Terms: Adolescent, Lymphoma, [SDV]Life Sciences [q-bio], childhood cancer survivors, Radboud University Medical Center, 610 Medicine & health, Bone Neoplasms, Wilms Tumor, 03 medical and health sciences, 0302 clinical medicine, 360 Social problems & social services, Risk Factors, late effects, Humans, Survivors, Hodgkin lymphoma, non-Hodgkin lymphoma, second cancers, subsequent primary lymphoma, Osteosarcoma, Leukemia, Lymphoma, Non-Hodgkin, Incidence, Neoplasms, Second Primary, Sarcoma, Radboudumc 18: Healthcare improvement science Haematology, Original Articles, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/etiology, Lymphoma/epidemiology, Lymphoma/complications, Lymphoma, Non-Hodgkin/therapy, Hodgkin Disease/epidemiology, Hodgkin Disease/complications, Leukemia/epidemiology, Sarcoma/epidemiology, Europe/epidemiology, Bone Neoplasms/complications, Wilms Tumor/complications, Kidney Neoplasms/complications, ta3122, ta3123, Hodgkin Disease, Kidney Neoplasms, 3. Good health, [SDV] Life Sciences [q-bio], Europe, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/36444554
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/288200
https://doi.org/10.1002/cncr.34561
https://pure.amsterdamumc.nl/en/publications/367987b2-d873-46ad-b0f2-523a9bf47787
https://doi.org/10.1002/cncr.34561
https://repository.ubn.ru.nl/handle/2066/288200
https://repository.ubn.ru.nl//bitstream/handle/2066/288200/288200.pdf
https://inserm.hal.science/inserm-04438179v1
https://doi.org/10.1002/cncr.34561
https://inserm.hal.science/inserm-04438179v1/document
https://serval.unil.ch/notice/serval:BIB_6A7859CCF91F
https://serval.unil.ch/resource/serval:BIB_6A7859CCF91F.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6A7859CCF91F9
https://boris.unibe.ch/175332/ -
8
Authors: et al.
Contributors: et al.
Source: Br J Cancer
British journal of cancer, vol. 128, no. 1, pp. 80-90
Sunguc, Ceren; Hawkins, Michael M; Winter, David L; Dudley, Isabelle M; Heymer, Emma J; Teepen, Jop C; Allodji, Rodrigue S; Belle, Fabiën N; Bagnasco, Francesca; Byrne, Julianne; Bárdi, Edit; Ronckers, Cécile M; Haddy, Nadia; Gudmundsdottir, Thorgerdur; Garwicz, Stanislaw; Jankovic, Momcilo; van der Pal, Helena J H; Mazić, Maja Česen; Schindera, Christina; Grabow, Desiree; ... (2023). Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. British journal of cancer, 128(1), pp. 80-90. Nature Publishing Group 10.1038/s41416-022-02016-w <http://dx.doi.org/10.1038/s41416-022-02016-w>Subject Terms: Adolescent, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, 610 Medicine & health, Bone Neoplasms, Article, 03 medical and health sciences, 0302 clinical medicine, 360 Social problems & social services, Risk Factors, Humans, Survivors, Leukemia, Incidence, Neoplasms, Second Primary, Sarcoma, ta3122, ta3123, Hodgkin Disease, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/etiology, Europe/epidemiology, Bone Neoplasms/complications, Leukemia/epidemiology, Mouth Neoplasms/epidemiology, Mouth Neoplasms/etiology, Mouth Neoplasms
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/36319851
http://juuli.fi/Record/0395665122
https://doi.org/10.1038/s4141602202016w
https://hal.science/hal-04250925v1
https://doi.org/10.1038/s41416-022-02016-w
https://pure.amsterdamumc.nl/en/publications/c4aba518-121b-4a9a-84a0-0d3a495084af
https://doi.org/10.1038/s41416-022-02016-w
https://serval.unil.ch/notice/serval:BIB_2A958E9646D1
https://serval.unil.ch/resource/serval:BIB_2A958E9646D1.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_2A958E9646D14
https://boris.unibe.ch/174452/
https://hdl.handle.net/2318/1880600
https://doi.org/10.1038/s41416-022-02016-w -
9
Authors: et al.
Source: BMC Med
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)Subject Terms: Male, Adult, Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Cancer epidemiology, Incidence [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Cancer registry data, Neoplasms, Second Primary/pathology [MeSH], Lung Neoplasms/epidemiology [MeSH], Second primary cancer, Germany/epidemiology [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], Standardized incidence ratio, Male [MeSH], United States/epidemiology [MeSH], Lung Neoplasms/pathology [MeSH], Lung cancer, Risk Assessment/methods [MeSH], Research Article, Registries [MeSH], Lung Neoplasms, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Germany, Humans, Registries, Aged, Aged, 80 and over, Incidence, Neoplasms, Second Primary, Middle Aged, United States, ddc, 3. Good health, Medicine, Female
File Description: application/pdf
-
10
Authors: et al.
Contributors: et al.
Source: American Journal of Gastroenterology. 117:794-797
Subject Terms: Esophageal Neoplasms, Squamous Cell Carcinoma of Head and Neck, Incidence, Carcinoma, Squamous Cell/epidemiology, Squamous Cell Carcinoma of Head and Neck/epidemiology, Esophageal Neoplasms/pathology, Neoplasms, Second Primary, 3. Good health, Head and Neck Neoplasms/complications, Cohort Studies, Neoplasms, Multiple Primary, 03 medical and health sciences, 0302 clinical medicine, Head and Neck Neoplasms, Risk Factors, Journal Article, Carcinoma, Squamous Cell, Humans, Neoplasms, Multiple Primary/pathology, Neoplasms, Second Primary/epidemiology
File Description: application/pdf
-
11
Authors: et al.
Source: Ann Hematol
Ann. Hematol., DOI: 10.1007/s00277-021-04647-0 (2021)Subject Terms: Adult, Male, 0301 basic medicine, Lymphoma, Mutation, Missense, 03 medical and health sciences, Nitriles, Humans, Hydroxyurea, Polycythemia Vera, Aged, Proportional Hazards Models, Aged, 80 and over, ddc:610, 0303 health sciences, Incidence, Neoplasms, Second Primary, Janus Kinase 2, Middle Aged, Cytoreductive Therapy, Non-melanoma Skin Carcinomas, Ruxolitinib, Secondary Malignancy, 3. Good health, Pyrimidines, Primary Myelofibrosis, Pyrazoles, Original Article, Female, Hydroxyurea/therapeutic use [MeSH], Aged, 80 and over [MeSH], Pyrazoles/adverse effects [MeSH], Aged [MeSH], Pyrazoles/therapeutic use [MeSH], Neoplasms, Second Primary/chemically induced [MeSH], Risk [MeSH], Mutation, Missense [MeSH], Neoplasms, Second Primary/epidemiology [MeSH], Proportional Hazards Models [MeSH], Male [MeSH], Primary Myelofibrosis/etiology [MeSH], Hydroxyurea/adverse effects [MeSH], Cytoreductive therapy, Pyrimidines [MeSH], Skin Neoplasms/chemically induced [MeSH], Lymphoma/chemically induced [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Janus Kinase 2/genetics [MeSH], Primary Myelofibrosis/chemically induced [MeSH], Adult [MeSH], Humans [MeSH], Polycythemia Vera/drug therapy [MeSH], Polycythemia Vera/genetics [MeSH], Incidence [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Skin Neoplasms/epidemiology [MeSH], Nitriles [MeSH], Polycythemia vera, Non-melanoma skin carcinomas, Secondary malignancy, Lymphoma/epidemiology [MeSH], Follow-Up Studies
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00277-021-04647-0.pdf
https://pubmed.ncbi.nlm.nih.gov/34462786
https://pubmed.ncbi.nlm.nih.gov/34462786/
https://link.springer.com/article/10.1007%2Fs00277-021-04647-0
https://paperity.org/p/271038365/ruxolitinib-treated-polycythemia-vera-patients-and-their-risk-of-secondary-malignancies
https://link.springer.com/content/pdf/10.1007/s00277-021-04647-0.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510903
https://pub.uni-bielefeld.de/record/2957095
https://doi.org/10.1007/s00277-021-04647-0
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=62859
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/10072
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/10072/WilleKai31082021.pdf
https://nbn-resolving.org/urn:nbn:de:hbz:294-100723
https://repository.publisso.de/resource/frl:6447793 -
12
Authors: et al.
Source: Cancer/Radiothérapie. 25:114-118
Subject Terms: Carcinoma, Ductal, Breast/epidemiology, Neoplasms, Radiation-Induced, Time Factors, Breast Neoplasms/surgery, Oncologie, Rare Diseases/mortality, Kaplan-Meier Estimate, Angiosarcome, Neoplasms, Radiation-Induced/epidemiology, Breast cancer, 0302 clinical medicine, Rare Diseases/epidemiology, Belgium, Angiosarcoma, Neoplasms, Second Primary/mortality, Human health sciences, Breast Neoplasms/etiology, Mastectomy, Aged, 80 and over, Unilateral Breast Neoplasms/epidemiology, Breast Neoplasms/epidemiology, Incidence, Carcinoma, Ductal, Breast, Hemangiosarcoma/etiology, Neoplasms, Second Primary, Middle Aged, 3. Good health, Radiation therapy, Neoplasms, Radiation-Induced/etiology, Oncology, Hemangiosarcoma/epidemiology, Female, Carcinoma, Ductal, Breast/radiotherapy, Hemangiosarcoma/mortality, Carcinoma, Ductal, Breast/mortality, Neoplasms, Radiation-Induced/mortality, Hemangiosarcoma, Unilateral Breast Neoplasms/mortality, Breast Neoplasms, Breast Neoplasms/radiotherapy, Sciences de la santé humaine, 03 medical and health sciences, Rare Diseases, Unilateral Breast Neoplasms/etiology, Hemangiosarcoma/surgery, Neoplasms, Radiation-Induced/surgery, Unilateral Breast Neoplasms, Humans, Chirurgie, Belgium/epidemiology, Cancer du sein, Radiothérapie, Aged, Retrospective Studies, Rare Diseases/etiology, Rare Diseases/surgery, Survival Analysis, Neoplasms, Second Primary/etiology, Surgery, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/surgery
Access URL: https://pubmed.ncbi.nlm.nih.gov/33487559
https://www.sciencedirect.com/science/article/pii/S127832182030319X
https://pubmed.ncbi.nlm.nih.gov/33487559/
https://europepmc.org/article/MED/33487559
https://www.ncbi.nlm.nih.gov/pubmed/33487559
https://hdl.handle.net/2268/335454
https://doi.org/10.1016/j.canrad.2020.05.020 -
13
Authors: et al.
Contributors: et al.
Source: European journal of cancer, Vol. 145 (2021) pp. 71-80
European journal of cancer, vol. 145, pp. 71-80
Waespe, Nicolas; Belle, Fabiën N.; Redmond, Shelagh; Schindera, Christina; Spycher, Ben D.; Rössler, Jochen; Ansari, Marc; Kuehni, Claudia E. (2021). Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer-A national cohort study. European journal of cancer, 145, pp. 71-80. Elsevier 10.1016/j.ejca.2020.11.042 <http://dx.doi.org/10.1016/j.ejca.2020.11.042>Subject Terms: Male, 0301 basic medicine, Genetic testing, Swiss childhood cancer registry, Cancer survivors, Second primary neoplasms, Pediatrics, 0302 clinical medicine, Neoplasms, Second Primary / diagnosis, Cancer Survivors, Risk Factors, Adolescent medicine, Neoplasms, 1306 Cancer Research, Registries, Child, ddc:618, Neoplastic Syndromes, Hereditary / epidemiology, Incidence, Age Factors, Hematopoietic Stem Cell Transplantation, Neoplasms, Second Primary, Neoplasms, Second Primary / epidemiology, 3. Good health, Early detection of cancer, Neoplastic Syndromes, Hereditary / diagnosis, Child, Preschool, 2730 Oncology, Female, Switzerland, Adolescent, 610 Medicine & health, Antineoplastic Agents, Risk Assessment, Switzerland / epidemiology, Young Adult, 03 medical and health sciences, 360 Social problems & social services, Neoplastic Syndromes, Hereditary, Humans, Radiotherapy / adverse effects, Genetic counselling, Antineoplastic Agents/adverse effects, Hematopoietic Stem Cell Transplantation/adverse effects, Infant, Infant, Newborn, Neoplasms, Second Primary/diagnosis, Neoplasms, Second Primary/epidemiology, Neoplastic Syndromes, Hereditary/diagnosis, Neoplastic Syndromes, Hereditary/epidemiology, Radiotherapy/adverse effects, Switzerland/epidemiology, Hereditary neoplastic syndromes, Radiotherapy, Antineoplastic Agents / adverse effects, Hematopoietic Stem Cell Transplantation / adverse effects, 10036 Medical Clinic
File Description: application/pdf; PIIS0959804920313794.pdf - application/pdf
Access URL: https://boris.unibe.ch/151289/1/Waespe_EurJCancer_2021.pdf
http://www.ejcancer.com/article/S0959804920313794/pdf
https://pubmed.ncbi.nlm.nih.gov/33423008
https://www.ncbi.nlm.nih.gov/pubmed/33423008
https://archive-ouverte.unige.ch/unige:156579
https://www.sciencedirect.com/science/article/pii/S0959804920313794
https://boris.unibe.ch/151289/
https://pubmed.ncbi.nlm.nih.gov/33423008/
https://www.sciencedirect.com/science/article/abs/pii/S0959804920313794
https://www.medrxiv.org/content/10.1101/2020.09.05.20180612v1
http://www.medrxiv.org/content/10.1101/2020.09.05.20180612v1
https://www.medrxiv.org/content/medrxiv/early/2020/09/07/2020.09.05.20180612.full.pdf
https://archive-ouverte.unige.ch/unige:156579
https://archive-ouverte.unige.ch/unige:156579
https://doi.org/10.1016/j.ejca.2020.11.042
https://serval.unil.ch/notice/serval:BIB_1ED8E884C076
https://serval.unil.ch/resource/serval:BIB_1ED8E884C076.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_1ED8E884C0769
https://boris.unibe.ch/151289/ -
14
Authors: et al.
Contributors: et al.
Source: Cardiovasc Intervent Radiol
Dadun. Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Cardiovascular and interventional radiology, vol. 44, no. 1, pp. 36-49Subject Terms: Male, 0301 basic medicine, Yttrium-90, Cardiac & Cardiovascular Systems, Carcinoma, Hepatocellular, Transarterial radioembolization, SIR-spheres, 03 medical and health sciences, MICROSPHERES, 0302 clinical medicine, Carcinoma, Hepatocellular/diagnosis, Carcinoma, Hepatocellular/epidemiology, Carcinoma, Hepatocellular/therapy, Embolization, Therapeutic/methods, Female, France/epidemiology, Humans, Incidence, Liver Neoplasms/diagnosis, Liver Neoplasms/epidemiology, Liver Neoplasms/therapy, Neoplasms, Second Primary/diagnosis, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/therapy, Quality of Life, Yttrium Radioisotopes/therapeutic use, Interim analysis, Radioembolization, SIRT, HEPATOCELLULAR-CARCINOMA, Yttrium Radioisotopes, Clinical Investigation, 1102 Cardiorespiratory Medicine and Haematology, Science & Technology, [PHYS.PHYS.PHYS-BIO-PH] Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph], INTERNAL RADIATION-THERAPY, Radiology, Nuclear Medicine & Medical Imaging, Liver Neoplasms, CIRT-FR Principal Investigators, Neoplasms, Second Primary, Embolization, Therapeutic, 3. Good health, SORAFENIB, EORTC, Nuclear Medicine & Medical Imaging, Cardiovascular System & Cardiology, TRIAL, France, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00270-020-02643-x.pdf
https://pubmed.ncbi.nlm.nih.gov/32975600
https://hdl.handle.net/10171/115046
https://pubmed.ncbi.nlm.nih.gov/32975600/
https://link.springer.com/article/10.1007/s00270-020-02643-x
https://link.springer.com/content/pdf/10.1007/s00270-020-02643-x.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728633
https://europepmc.org/article/PMC/PMC7728633
https://serval.unil.ch/resource/serval:BIB_8216514E3692.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8216514E36921
https://serval.unil.ch/notice/serval:BIB_8216514E3692 -
15
Authors: et al.
Source: Graefes Arch Clin Exp Ophthalmol
Subject Terms: 2. Zero hunger, 03 medical and health sciences, Lacrimal Apparatus [MeSH], Humans [MeSH], Ocular adnexa, Orbit [MeSH], Second malignancies, Neoplasms, Second Primary/diagnosis [MeSH], Eye Neoplasms/diagnosis [MeSH], Oncology, Orbit, Epidemiology, Neoplasms, Second Primary/epidemiology [MeSH], Conjunctiva [MeSH], Eye, Lymphoma, Non-Hodgkin/epidemiology [MeSH], Eye Neoplasms/epidemiology [MeSH], Lymphoma, Non-Hodgkin/diagnosis [MeSH], 0302 clinical medicine, Eye Neoplasms, Lymphoma, Non-Hodgkin, Lacrimal Apparatus, Humans, Neoplasms, Second Primary, Conjunctiva, 3. Good health
Access URL: https://link.springer.com/content/pdf/10.1007/s00417-020-04896-1.pdf
https://pubmed.ncbi.nlm.nih.gov/32870371
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843581
https://link.springer.com/article/10.1007/s00417-020-04896-1
https://europepmc.org/article/MED/32870371
https://pubmed.ncbi.nlm.nih.gov/32870371/
https://link.springer.com/content/pdf/10.1007/s00417-020-04896-1.pdf
https://repository.publisso.de/resource/frl:6467526 -
16
Authors: et al.
Source: Liječnički vjesnik
CODEN LIVJA5
Volume 141
Issue 5-6Subject Terms: Homologous, VREMENSKI ČIMBENICI, transplantacija krvotvornih matičnih stanica, Long Term Adverse Effects, NEOPLASMS, SECOND PRIMARY – epidemiology, etiology, TRANSPLANTACIJA KRVOTVORNIH MATIČNIH STANICA – neželjeni učinci, statistički podatci, RETROSPEKTIVNE STUDIJE, ENDOKRINE BOLESTI – epidemiologija, etiologija, TRANSPLANTATION, HOMOLOGOUS, QUALITY OF LIFE, Cancer Survivors, KRONIČNA BOLEST, RETROSPECTIVE STUDIES, KARDIOVASKULARNE BOLESTI – epidemiologija, etiologija, Bone Marrow Transplantation, HEMATOPOIETIC STEM CELL TRANSPLANTATION – adverse effects, statistics and numerical data, SURVIVORS, 2. Zero hunger, Transplantation, TIME FACTORS, transplantacija krvotvornih matičnih stanica, transplantacija koštane srži, alogena transplantacija, dugoročni negativni učinci, dugoročno preživljenje, dugoročni negativni učinci, transplantacija koštane srži, Hematopoietic Stem Cell Transplantation, PREŽIVJELI, alogena transplantacija, 3. Good health, ENDOCRINE SYSTEM DISEASES – epidemiology, etiology, BOLEST PRESATKA PROTIV PRIMATELJA – epidemiologija, etiologija, SEKUNDARNI TUMORI – epidemiologija, etiologija, CHRONIC DISEASE, dugoročno preživljenje, KVALITETA ŽIVOTA, CARDIOVASCULAR DISEASES – epidemiology, etiology, GRAFT VS HOST DISEASE – epidemiology, etiology, ALOGENA TRANSPLANTACIJA
File Description: application/pdf
-
17
Authors: et al.
Contributors: et al.
Source: J Natl Cancer Inst
Bright, C J, Hawkins, M M, Winter, D L, Alessi, D, Allodji, R S, Bagnasco, F, Bárdi, E, Bautz, A, Byrne, J, Feijen, E A M, Fidler, M M, Garwicz, S, Grabow, D, Gudmundsdottir, T, Guha, J, Haddy, N, Jankovic, M, Kaatsch, P, Kaiser, M, Kuehni, C E, Linge, H, Øfstaas, H, Ronckers, C M, Skinner, R, Teepen, J C, Terenziani, M, Vu-Bezin, G, Wesenberg, F, Wiebe, T, Sacerdote, C, Jakab, Z, Haupt, R, Lähteenmäki, P, Zaletel, L Z, Kuonen, R, Winther, J F, de Vathaire, F, Kremer, L C, Hjorth, L, Reulen, R C & PanCareSurFup Consortium 2018, 'Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe', Journal of the National Cancer Institute, vol. 110, no. 6, pp. 649-660. https://doi.org/10.1093/jnci/djx235
Bright, Chloe J; Hawkins, Mike M; Winter, David L; Alessi, Daniela; Allodji, Rodrigue S; Bagnasco, Francesca; Bárdi, Edit; Bautz, Andrea; Byrne, Julianne; Feijen, Elizabeth A M; Fidler, Miranda M; Garwicz, Stanislaw; Grabow, Desiree; Gudmundsdottir, Thorgerdur; Guha, Joyeeta; Haddy, Nadia; Jankovic, Momcilo; Kaatsch, Peter; Kaiser, Melanie; Kuehni, Claudia E; ... (2018). Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. Journal of the National Cancer Institute JNCI, 110(6), pp. 649-660. Oxford University Press 10.1093/jnci/djx235 <http://dx.doi.org/10.1093/jnci/djx235>Subject Terms: Adult, Male, Time Factors, 2ND MALIGNANCIES, Adolescent, [SDV]Life Sciences [q-bio], 610 Medicine & health, Soft Tissue Neoplasms, Europe/epidemiology, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Soft Tissue Neoplasms/epidemiology, Cancer Survivors, 360 Social problems & social services, Risk Factors, Humans, Sarcoma/epidemiology, Registries, SECONDARY SARCOMAS, Child, BRITAIN, Incidence, Infant, Newborn, Infant, Neoplasms, Second Primary, Sarcoma, Articles, CHEMOTHERAPY, Middle Aged, ta3122, TUMORS, 3. Good health, [SDV] Life Sciences [q-bio], Europe, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Child, Preschool, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Neoplasms, Second Primary/epidemiology, Female, HEREDITARY RETINOBLASTOMA, Cancer Survivors/statistics & numerical data, RADIOTHERAPY, NEOPLASMS, Follow-Up Studies
File Description: application/pdf
Access URL: https://academic.oup.com/jnci/article-pdf/110/6/649/25041826/djx235.pdf
https://pubmed.ncbi.nlm.nih.gov/29165710
http://juuli.fi/Record/0365782318
https://doi.org/10.1093/jnci/djx235
https://academic.oup.com/jnci/article/110/6/649/4643198
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005019
https://www.ncbi.nlm.nih.gov/pubmed/29165710
https://lup.lub.lu.se/search/publication/ffaaca2a-fb8a-4e3e-b9d9-1f7fd6ca922a
https://research.birmingham.ac.uk/portal/files/112706195/djx235.pdf
https://boris.unibe.ch/107539/
https://pure.amsterdamumc.nl/en/publications/ae432de2-ce8f-407a-b6c9-6a6a818a7080
https://doi.org/10.1093/jnci/djx235
https://inserm.hal.science/inserm-04439772v1
https://inserm.hal.science/inserm-04439772v1/document
https://doi.org/10.1093/jnci/djx235
https://pure.au.dk/portal/en/publications/7116b8b5-2ae4-4dec-b4f4-70e7717a8d71
https://boris.unibe.ch/107539/
https://pure.au.dk/portal/en/publications/7116b8b5-2ae4-4dec-b4f4-70e7717a8d71
https://pure.au.dk/ws/files/196314994/djx235.pdf
https://doi.org/10.1093/jnci/djx235 -
18
Authors: et al.
Contributors: et al.
Source: Fidler, Miranda M; Reulen, Raoul C; Winter, David L; Allodji, Rodrigue S; Bagnasco, Francesca; Bárdi, Edit; Bautz, Andrea; Bright, Chloe J; Byrne, Julianne; Feijen, Elizabeth A M; Garwicz, Stanislaw; Grabow, Desiree; Gudmundsdottir, Thorgerdur; Guha, Joyeeta; Haddy, Nadia; Jankovic, Momcilo; Kaatsch, Peter; Kaiser, Melanie; Kuonen, Rahel; Linge, Helena; ... (2018). Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. Journal of the National Cancer Institute JNCI, 110(2), djx165. Oxford University Press 10.1093/jnci/djx165 <http://dx.doi.org/10.1093/jnci/djx165>
Fidler, M M, Reulen, R C, Winter, D L, Allodji, R S, Bagnasco, F, Bardi, E, Bautz, A, Bright, C J, Byrne, J, Feijen, E A M, Garwicz, S, Grabow, D, Gudmundsdottir, T, Guha, J, Haddy, N, Jankovic, M, Kaatsch, P, Kaiser, M, Kuonen, R, Linge, H, Hawkins, M M & Winther, J F 2018, 'Risk of subsequent bone cancers among 69 460 five-year survivors of childhood and adolescent cancer in Europe', Journal of the National Cancer Institute, vol. 110, no. 2, pp. 183-194. https://doi.org/10.1093/jnci/djx165Subject Terms: Adult, Male, Adolescent, [SDV]Life Sciences [q-bio], 610 Medicine & health, Bone Neoplasms, Europe/epidemiology, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Retinoblastoma/epidemiology, 360 Social problems & social services, Humans, Sarcoma/epidemiology, Survivors, Child, Osteosarcoma, Retinoblastoma, Neoplasms, Second Primary, Sarcoma, ta3122, ta3123, Survivors/statistics & numerical data, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Osteosarcoma/epidemiology, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Follow-Up Studies, Oncology, Cancer Research, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Bone Neoplasms/epidemiology, Neoplasms, Second Primary/epidemiology
File Description: application/pdf
Access URL: https://academic.oup.com/jnci/article-pdf/110/2/183/24367868/djx165.pdf
https://pubmed.ncbi.nlm.nih.gov/28954302
http://juuli.fi/Record/0336452518
https://portal.research.lu.se/portal/sv/publications/risk-of-subsequent-bone-cancers-among-69-460-fiveyear-survivors-of-childhood-and-adolescent-cancer-in-europe(7de44e72-e27c-45f0-9f1a-bdc0f2a27588).html
https://academic.oup.com/jnci/article/110/2/183/4237499
https://lup.lub.lu.se/search/publication/7de44e72-e27c-45f0-9f1a-bdc0f2a27588
https://www.ncbi.nlm.nih.gov/pubmed/28954302
https://pubmed.ncbi.nlm.nih.gov/28954302/
https://www.hirsla.lsh.is/handle/2336/620424
https://boris.unibe.ch/106587/
https://pure.au.dk/portal/en/publications/abb425c0-0990-46ff-af5c-0fb5ebc3e66f
http://www.scopus.com/inward/record.url?scp=85030621565&partnerID=8YFLogxK
https://doi.org/10.1093/jnci/djx165 -
19
Authors: et al.
Contributors: et al.
Source: Br J Cancer
Van Eggermond, A M, Schaapveld, M, Janus, C P M, De Boer, J P, Krol, A D, Zijlstra, J M, Van Der Maazen, R W M, Kremer, L C, Van Leerdam, M E, Louwman, M W J, Visser, O, De Bruin, M L, Aleman, B M P & Van Leeuwen, F E 2017, 'Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors', British Journal of Cancer, vol. 117, no. 3, pp. 306-314. https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117, 3, pp. 306-314
van Eggermond, A M, Schaapveld, M, Janus, C P, de Boer, J P, Krol, A D, Zijlstra, J M, van der Maazen, R W, Kremer, L C, van Leerdam, M E, Louwman, M W, Visser, O, De Bruin, M L, Aleman, B M & van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', B J C, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177Subject Terms: Male, Neoplasms, Radiation-Induced, Prednisone/therapeutic use, chemotherapy, radiation therapy, Neoplasms, Radiation-Induced/epidemiology, 0302 clinical medicine, Risk Factors, Neoplasms, Taverne, Antineoplastic Combined Chemotherapy Protocols, Radiation-Induced/epidemiology, Survivors, Hodgkin Disease/drug therapy, Netherlands, Neoplasms, Second Primary, long-term complications, Middle Aged, Hodgkin Disease, Antineoplastic Agents/administration & dosage, 3. Good health, EMC MM-03-32-04, Second Primary, Vincristine, Female, Colorectal Neoplasms, Adult, Vincristine/therapeutic use, Vinblastine/therapeutic use, Colon, Diaphragm, Second Primary/epidemiology, colorectal cancer, Netherlands/epidemiology, Antineoplastic Agents, Vinblastine, Mechlorethamine/therapeutic use, Young Adult, Bleomycin, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Journal Article, Bleomycin/therapeutic use, Humans, Mechlorethamine, Colorectal Neoplasms/epidemiology, procarbazine, Rectum, Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences, Procarbazine/administration & dosage, Radiation-Induced, Doxorubicin, 13. Climate action, Procarbazine, second malignant neoplasm, Clinical Study, Prednisone, Neoplasms, Second Primary/epidemiology, Doxorubicin/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Hodgkin lymphoma, Follow-Up Studies
File Description: application/pdf
Access URL: https://www.nature.com/articles/bjc2017177.pdf
https://pubmed.ncbi.nlm.nih.gov/28632726
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/177780
https://doi.org/10.1038/bjc.2017.177
https://pure.eur.nl/en/publications/e4af9a51-dbee-47dd-8dd2-afd2859bd220
https://doi.org/10.1038/bjc.2017.177
https://www.nature.com/articles/bjc2017177
https://repub.eur.nl/pub/101953
https://repository.ubn.ru.nl/handle/2066/177780
https://pubmed.ncbi.nlm.nih.gov/28632726/
https://europepmc.org/article/MED/28632726
http://repository.ubn.ru.nl/handle/2066/177780
https://research.vumc.nl/en/publications/f195bf10-ed3c-481f-82cd-3f7d5809fa50
https://hdl.handle.net/1887/115418
https://pure.amsterdamumc.nl/en/publications/71914cf0-37c8-4b7a-9bb7-5ea262866022
https://doi.org/10.1038/bjc.2017.177
https://curis.ku.dk/ws/files/203454187/bjc2017177.pdf
https://dspace.library.uu.nl/handle/1874/428442 -
20
Authors: et al.
Contributors: et al.
Source: BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC cancer, vol. 20, no. 1, pp. 51Subject Terms: Adult, Male, Cancer Research, Adolescent, Alcohol Drinking, Retrospective, 610 Medicine & health, Aged, Alcohol Drinking/adverse effects, Cancer Survivors/statistics & numerical data, Female, Humans, Incidence, Middle Aged, Neoplasms/complications, Neoplasms/therapy, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/etiology, Neoplasms, Second Primary/pathology, Registries, Retrospective Studies, Risk Factors, Smoking/adverse effects, Switzerland/epidemiology, Young Adult, Cohort study, Relative risk, Second primary cancer, Switzerland, 03 medical and health sciences, 0302 clinical medicine, 1311 Genetics, Cancer Survivors, Neoplasms, Genetics, 1306 Cancer Research, RC254-282, Smoking, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoplasms, Second Primary, 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI), 3. Good health, Oncology, 2730 Oncology, Research Article
File Description: application/pdf; feller-relativerisk-s12885-019-6452-0.pdf - application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/31964352
https://doaj.org/article/31036b8f0e8e4da28148ffaf76000747
https://link.springer.com/article/10.1186/s12885-019-6452-0
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974968
https://link.springer.com/content/pdf/10.1186/s12885-019-6452-0.pdf
https://www.ncbi.nlm.nih.gov/pubmed/31964352
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-6452-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974968
https://serval.unil.ch/resource/serval:BIB_309F3E21A26F.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_309F3E21A26F
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_309F3E21A26F2
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science